SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Crispr Therapeutics AG (CRSP)

CRSP RSS Feed
Add CRSP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/23/2017 4:14:46 PM - Followers: 11 - Board type: Free - Posts Today: 0

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
CRSP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
CRSP News: Statement of Changes in Beneficial Ownership (4) 08/18/2017 04:17:52 PM
CRSP News: Statement of Changes in Beneficial Ownership (4) 08/16/2017 04:15:30 PM
CRSP News: Amended Statement of Beneficial Ownership (sc 13d/a) 08/14/2017 05:24:47 PM
CRSP News: Amended Statement of Changes in Beneficial Ownership (4/a) 08/11/2017 05:05:14 PM
CRSP News: Current Report Filing (8-k) 08/10/2017 04:47:02 PM
PostSubject
#1   This will be huge, and I've got myself Migs123 05/23/17 04:14:46 PM
PostSubject